Markets · Sweden
Nasdaq Stockholm
923 stocks listed, 873 traded in the last 30 days and shown below. Prices in SEK. Price, return and technical signals for now; the fundamental X-Ray follows when fundamentals data for this market is added. Data as of 27 Oct 2026.
| Company | Close | Today | 3 months | 1 year | RSI | vs 52w high |
|---|---|---|---|---|---|---|
| CLIME-B Climeon AB (publ) | 2.690 | +1.9% | +8.5% | −33.1% | 44 | −44.9% |
| PILA Pila Pharma AB | 1.500 | −2.3% | +27.7% | −33.3% | 43 | −40.0% |
| IMMU Mendus AB (publ) | 5.350 | −2.6% | −19.1% | −20.0% | 39 | −37.0% |
| CARDEO Cardeon | 0.052 | −1.9% | −3.7% | −18.8% | 39 | −44.7% |
| IRIS Irisity AB | 0.227 | +0.0% | +14.6% | +57.4% | 45 | −66.1% |
| 18.84 | +1.2% | +9.7% | −56.1% | 63 | −59.4% | |
| BINV BioInvent International AB | 20.80 | +1.5% | −11.1% | −26.5% | 37 | −40.3% |
| SMOL Smoltek Nanotech Holding AB | 1.420 | – | −13.9% | +218.4% | 62 | −76.3% |
| STAR-B Starbreeze AB (publ) | 0.095 | −1.1% | +4.5% | −32.3% | 42 | −34.7% |
| CINPHA Cinclus Pharma | 11.96 | −0.3% | −1.8% | −26.3% | 42 | −39.1% |
| HUSQ-A Husqvarna AB (publ) | 32.00 | −2.3% | −15.0% | −30.7% | 38 | −34.2% |
| AIXIA-B Aixia Group AB ser. B | 83.60 | +0.0% | +10.9% | −30.3% | 49 | −40.1% |
| OGUN-B Ogunsen AB Series B | 20.60 | +0.0% | −19.2% | −13.9% | 38 | −38.5% |
| K2A-B K2A Knaust & Andersson Fastigheter... | 3.860 | −1.0% | −7.4% | −28.4% | 38 | −35.7% |
| INFREA Infrea AB | 11.20 | −2.2% | −14.8% | −11.1% | 29 | −34.1% |
| ORT-B Ortoma AB Series B | 11.26 | +61.3% | +25.8% | −30.7% | 86 | −42.7% |
| MEAB-B Malmbergs Elektriska AB (publ) | 29.90 | +3.8% | −14.6% | −0.6% | 51 | −34.9% |
| 1.160 | −0.4% | −10.8% | −35.4% | 39 | −37.8% | |
| AAC AAC Clyde Space AB (publ) | 102.40 | +2.5% | −10.5% | +9.5% | 49 | −44.9% |
| ERMA Enorama Pharma AB | 0.956 | −4.4% | +203.5% | −65.9% | 55 | −66.6% |
| AVEN Avensia publ AB | 5.600 | +0.0% | −9.4% | −27.2% | 48 | −40.7% |
| MSON-B Midsona AB (publ) | 9.300 | −1.3% | −19.8% | +15.4% | 30 | −40.0% |
| VOLO Volati AB | 24.65 | −0.2% | +1.9% | −39.7% | 49 | −63.2% |
| MANG Mangold Fondkommission AB | 1,470.00 | +1.4% | −12.5% | −27.2% | 39 | −28.6% |
| 209.50 | +2.4% | +1.5% | −23.0% | 47 | −43.5% | |
| RAKE Raketech Group Holding | 1.950 | −2.5% | +2.6% | −17.0% | 72 | −25.0% |
| 4.650 | +0.9% | +10.8% | −54.1% | 52 | −55.4% | |
| SOSI Sotkamo Silver | 3.440 | +5.4% | −12.9% | +225.1% | 30 | −56.3% |
| CCC Cavotec SA | 10.80 | +4.9% | −15.0% | −30.8% | 43 | −34.3% |
| ENEA Enea AB | 52.60 | +4.2% | −6.4% | −22.3% | 34 | −43.3% |
| STATE Safestate Group | 22.50 | −3.8% | −16.8% | +6.4% | 52 | −33.6% |
| BONAV-B Bonava AB (publ) | 7.640 | +0.0% | −23.0% | −32.1% | 33 | −43.9% |
| CASE Case Group AB | 19.60 | −2.0% | −5.8% | −18.9% | 39 | −34.7% |
| ATIC Actic Group AB | 25.55 | +0.4% | −7.9% | +3.4% | 56 | −35.5% |
| QSYS Qualisys Holding AB (publ) | 35.80 | −0.4% | −30.5% | −30.2% | 14 | −43.4% |
| GTAB-B Glycorex Transplantation B | 1.485 | +1.0% | −10.5% | −24.8% | 50 | −25.8% |
| 136.40 | +4.0% | −21.6% | −15.4% | 53 | −35.8% | |
| ARFA Arctic Falls | 68.90 | −1.6% | −1.9% | – | 54 | −42.5% |
| SFTR Safeture AB | 3.860 | +0.0% | −6.3% | −22.8% | 47 | −29.8% |
| CAT-B Catella AB (publ) | 16.10 | +2.2% | −18.8% | −43.9% | 41 | −48.3% |
| ONCO Oncopeptides AB | 1.660 | −0.6% | +2.3% | −66.4% | 41 | −73.0% |
| HUMBLE Humble Group AB | 5.410 | −0.7% | −7.4% | −37.8% | 51 | −39.0% |
| BOTX Botnia Gold AB (publ) | 10.20 | −1.5% | −14.9% | −22.7% | 43 | −41.0% |
| SPEONE Spectrumone publ AB | 0.159 | −0.9% | +3.3% | +7.1% | 50 | −45.0% |
| SIMRIS-B Simris Alg AB (publ) | 0.120 | −1.6% | −5.5% | +0.8% | 52 | −38.7% |
| GOMERO Gomero Group AB | 12.70 | +0.8% | +7.2% | −34.8% | 39 | −49.6% |
| NEXAM Nexam Chemical Holding AB | 2.530 | +3.3% | −20.9% | −25.1% | 48 | −35.1% |
| SYNEXO Synexo Group | 0.128 | −1.5% | −6.6% | −22.4% | 44 | −48.8% |
| REDS Redsense Medical AB | 3.740 | – | −13.6% | −8.6% | 56 | −34.4% |
| NETI-B Net Insight AB (publ) | 2.420 | −2.8% | +6.1% | −37.4% | 31 | −47.4% |
Prices are end-of-day closes in SEK. Educational only, not financial advice.